Cumberland Pharmaceuticals Reports Fourth Quarter Revenue Growth Of 16%
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Cumberland Pharmaceuticals (CPIX) Tops Q4 EPS and Revenue
February 26, 2019 4:35 PM ESTCumberland Pharmaceuticals (NASDAQ: CPIX) reported Q4 EPS of $0.10, $0.26 better than the analyst estimate of ($0.16). Revenue for the quarter came in at $13.5 million versus the consensus estimate of $10.98 million.
For earnings history and earnings-related data on Cumberland Pharmaceuticals (CPIX) click here.
... More


